Avanir Pharma Balance Sheet - Annual (NASDAQ:AVNR)

Add to My Stocks
$16.96 $0 (0%) AVNR stock closing price Jan 13, 2015 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Avanir Pharma stock analysis. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Avanir Pharma stock analysis, and provides insights into the firm's financial performance. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. The balance sheet shows total liabilities of $33.59M and shareholders equity of $273.38M. Avanir Pharma revenue and Avanir Pharma operating cash flow are important in understanding the financial capacity of the company.

View latest 10 year balance sheet data to check Avanir Pharma financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Oct - Sep2014201320122011201020092008
Marketable Securities--1.05M----
Raw Materials-------
Work In Progress-------
Finished Goods-------
Notes Receivable-------
Other Current Assets3.99M2.38M2.43M1.96M--1.26M
Total Current Assets
Property Plant & Equipment8.38M4.98M4.38M3.57M2.45M2.12M2.39M
Accumulated Depreciation4.75M3.39M2.57M1.87M2M1.81M1.58M
Net Property Plant & Equipment
Investment & Advances1.3M1.3M1.3M1.63M---
Other Non-Current Assets------1.31M
Deferred Charges-------
Deposits & Other Assets--1.07M1.13M---
Total Assets
Notes Payable-7.94M2.16M----
Accounts Payable6.72M5.87M2.93M3.26M2.1M1.21M-
Current Portion Long-Term Debt-------
Current Portion Capital Leases-------
Accrued Expenses25.36M19.68M12.66M7.18M3.21M2.34M3.07M
Income Taxes Payable-------
Other Current Liabilities-1.28M2.55M3.74M2.39M2.28M2.33M
Total Current Liabilities
Deferred Taxes/Income--1.49M4.05M6.07M7.62M10.15M
Convertible Debt-------
Long-Term Debt-21.42M26.69M----
Non-Current Capital Leases-------
Other Long-Term Liabilities1.5M1.39M-----
Total Liabilities
Minority Interest-------
Preferred Stock-------
Common Stock Net------284.99M
Capital Surplus824.34M518.99M461.88M436.64M332.1M297.92M-
Retained Earnings-550.97M-500.53M-425.06M-365.31M-304.68M-277.99M-255.99M
Treasury Stock-------
Other Liabilities-------
Shareholders Equity273.38M18.47M36.83M71.33M28M19.94M29M
Total Liabilities & Shareholders Equity306.98M76.07M86.01M89.64M42.14M34.06M45.9M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the Avanir Pharma stock price by looking at Avanir Pharma historical stock prices. One can compare PE with industry average by looking at the Avanir Pharma PE ratio chart. The common balance sheet items are:

  • Assets: Anything that the Avanir Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Avanir Pharma had total assets of $306.98M.
  • Liabilities: The total liabilities of Avanir Pharma for the year 2014 total to $33.59M. Liabilities for a company like Avanir Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.